Home/ Stocks/ BDX

Becton, Dickinson and Co.

BDX XNYS

$176.86 -0.21 (-0.12%) ▼ 15-min delayed

Open

$175.26

High

$177.54

Low

$173.29

Volume

1.85M

Market Cap

$48.79B

About Becton, Dickinson and Co.

Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.

Sector: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS Employees: 72.0K Website →

Key Financials

Period	Revenue	Net Income	EPS
Q2 2026	$4.71B	$-311,000,000	$-1.11
Q1 2026	$5.25B	$382.00M	$1.34
FY 2025	$21.84B	$1.68B	$5.83
Q3 2025	$5.51B	$574.00M	$2.00

Related Market News

No specific coverage for BDX yet. Check out our latest market news or earnings calendar.

Get BDX Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Becton, Dickinson and Co..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.